期刊文献+

中美COVID-19体外诊断产品对比分析 被引量:1

Comparative analysis of COVID-19 in vitro diagnostic products between China and USA
下载PDF
导出
摘要 本文梳理了2020年中美两国批准上市的新型冠状病毒肺炎(COVID-19)体外诊断产品情况,对比分析了两国产品在上市趋势、来源、类别、检测样本、检测靶标和检测方法方面的异同,并据此展望了COVID-19体外诊断技术未来的发展方向,旨在为我国体外诊断产品的发展提供有益参考。 This paper reviews COVID-19 in vitro diagnosis products approved by China and the United States in 2020,analyzes the similarities and differences between the two countries in marketing trends,sources,categories,test samples,detection targets and detection methods,and looks forward to the future development direction of COVID-19 in vitro diagnosis technology.The purpose of this paper is to provide a useful reference for the development of epidemic prevention and control and in vitro diagnosis in China.
作者 王燕妮 张泽波 WANG Yanni;ZHANG Zebo(Taizhou Institute for Drug Control,Taizhou,Jiangsu 225300,China;Taizhou Pharmaceutical Technology Transfer Center,Taizhou,Jiangsu 225300,China)
出处 《国际检验医学杂志》 CAS 2021年第S01期200-206,共7页 International Journal of Laboratory Medicine
关键词 COVID-19体外诊断产品 新型冠状病毒 中美对比 核酸检测 抗原抗体检测 COVID-19 In vitro diagnostic products 2019-nCoV comparison between China and USA nucleic acid detection antigen test and serological detection
  • 相关文献

参考文献1

二级参考文献7

共引文献54

同被引文献14

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部